OSAKA, Japan, March 11, 2024 /PRNewswire/ Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University (Cambridge, MA, USA; "Harvard") aiming at validating novel therapeutic targets. In this alliance, as part of our ongoing open innovation initiative to collaborate.
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Ono Enters Into A Research Collaboration Agreement With Inveniai To Identify Novel Therapeutic Targets menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a drug discovery.
Ono Enters into Research Collaboration with UK Dementia Research Institute tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.